Quaternized Thiomers for Antibacterial Activity and Hyperinflammation Mitigation
ACS Infectious Diseases · 13.03.2026 · 12 (3) · 1192-1203
DOI: 10.1021/acsinfecdis.5c01145 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 25.02.2026. Verfasst von Dipanjana Patra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru, Karnataka 560064, Indi…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Inflammation, Sulfhydryl Compounds. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Jawaharlal Nehru Centre for Advanced Scientific Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru, Karnataka 560064, India.
- Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru, Karnataka 560064, India.
- School of Advanced Materials, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru, Karnataka 560064, India.
ORCID-Profile: Jayanta Haldar
Förderung
- Jawaharlal Nehru Centre for Advanced Scientific Research
Zitieren
APA
Patra, D., Chakravarty, S., Singh, H., & Haldar, J. (2026). Quaternized Thiomers for Antibacterial Activity and Hyperinflammation Mitigation. ACS Infectious Diseases, 12(3), 1192-1203. https://doi.org/10.1021/acsinfecdis.5c01145
Vancouver
Patra D, Chakravarty S, Singh H, Haldar J. Quaternized Thiomers for Antibacterial Activity and Hyperinflammation Mitigation. ACS Infectious Diseases. 2026;12(3):1192-1203. doi:10.1021/acsinfecdis.5c01145
BibTeX
@article{Patra2026,
author = {Patra, Dipanjana and Chakravarty, Sayan and Singh, Himani and Haldar, Jayanta},
title = {Quaternized Thiomers for Antibacterial Activity and Hyperinflammation Mitigation},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {3},
pages = {1192--1203},
doi = {10.1021/acsinfecdis.5c01145}
}
EUVIMED